Equaline Original Prescription Strength, loratadine orally disintegrating tablets, USP, 10 mg, pa...
FDA Drug Recall #D-0025-2016 — Class III — July 28, 2015
Recall Summary
| Recall Number | D-0025-2016 |
| Classification | Class III — Low risk |
| Date Initiated | July 28, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ohm Laboratories, Inc. |
| Location | North Brunswick, NJ |
| Product Type | Drugs |
| Quantity | 43,344 boxes |
Product Description
Equaline Original Prescription Strength, loratadine orally disintegrating tablets, USP, 10 mg, packaged in a) 10-count tablets per box, NDC 41163-528-69, UPC 0 4116347138 2; and b) 30-count tablets per box, NDC 41163-528-31, UPC 0 4116346654 8; Distributed by: Supervalu Inc. Eden Prarie, MN 55344 USA
Reason for Recall
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Distribution Pattern
Nationwide.
Lot / Code Information
Batch Numbers: a) 2617892, Exp 5/31/2016; 2625092, Exp 6/30/2016; 2544486, 2544488, Exp 7/31/2016; 2600127, Exp 2/29/2016; 2644265, Exp 9/30/2016 b) 2544486, 2544488, Exp 7/31/2016; 2600127, Exp 2/29/2016; 2644265, Exp 9/30/2016
Other Recalls from Ohm Laboratories, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0030-2016 | Class III | Leader Loratadine Orally Disintegrating Tablets... | Jul 28, 2015 |
| D-0037-2016 | Class III | Sunmark loratadine Orally Disintegrating Tablet... | Jul 28, 2015 |
| D-0034-2016 | Class III | Safeway Care Loratadine Orally Disintegrating T... | Jul 28, 2015 |
| D-0033-2016 | Class III | Premier Value Loratadine Orally Disintegrating ... | Jul 28, 2015 |
| D-0035-2016 | Class III | TopCare LORATIDINE ORALLY DISINTEGRATING TABLET... | Jul 28, 2015 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.